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TAKING SIDES IN THE VACCINE/AUTISM LEGAL BATTLE
Bartholomew C Wacek*
I. INTRODUCTION
Autism is a health disorder that affects children and is characterized by
the impairment of normal neuronal development. In the United States,
the prevalence of autism has increased remarkably as data shows that
approximately one in 300 children had the disorder in the mid-1990s
compared to one in approximately 2,500 children in the mid-1980s.1
Epidemiological studies in 2001 suggest that autism may affect as
many as one in 150 children in the United States. 2
The etiology (or cause) of autism is not known. However, the
biological picture of autism in the human body is very similar to that of
mercury poisoning.3 Children may be exposed to mercury by a variety
of sources (e.g., including eating fish that has high levels of mercury).4
Another potential source for toxic mercury exposure is childhood
vaccines.
Prior to 1999, childhood vaccines contained a preservative
called thimerosal.6 Thimerosal is an organic mercury compound that
was added to vaccines to prevent infections from fungus and bacteria
The level of thimerosal in one vaccine shot is low. However, children
now receive as many as 18 vaccine shots in their first two years of life,
and combining the thimerosal levels of all these shots means that a
child might theoretically have mercury levels that slightly exceed the
United States Environmental Protection Agency (EPA) guidelines.8
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Because of this fact, the Academy of Pediatrics and the United States
Public Health" Service in 1999 recommended that thimerosal be
removed from vaccines. 9
Do vaccines that contain thimerosal cause autism? The
scientific evidence to answer this question is inconclusive.' In October
2001, the Institute of Medicine issued a report stating that there was no
hard evidence that thimerosal caused autism, but the report also said it
was "biologically plausible" for autism to be caused by mercury
poisoning." In February 2004, the Institute of Medicine said it would
re-examine the autism/vaccine debate by studying the latest research in
this area.
While scientists continue to debate whether there is a link
between childhood vaccines and autism, parents of autistic children
have filed hundreds of lawsuits against vaccine makers.' 3 Parents of
autistic children seek compensatory and punitive damages from vaccine
makers in civil courts across the United States. By federal law, these
petitioners must first file their claim in the United States Court of
Federal Claims ("Vaccine Court") as stipulated by the National
12

Vaccine Injury Compensation Act ("NVICA"). 4

The NVICA was enacted in 1986 by Congress and provides a
no-fault remedial scheme for vaccine related injuries." A plaintiff
needs only prove causation between the vaccine and the injury (and not
negligence on the part of the vaccine maker) to be rewarded damages.16
The NVICA expressly prohibits filing a civil action for damages
without first filing a petition with the Vaccine Court.
Parents of autistic children, however, would rather bypass the
federal Vaccine Court because damages for pain, suffering, and death
are capped at $250,000.7 Attorneys for these parents state that awards
would likely be higher if they could first try their cases in civil courts
where juries have been known to award damages in the millions of
dollars for medical injury cases. 8 As a result, many attorneys for the
parents of autistic children bypass the NVICA by characterizing their
9 Susan Warner, New Vaccine Clause Angers Parents of Autistic; Amendment
Buried in Homeland Secunty Law Restricts Right to Sue Makers of Drug
Preservative,WASH. POST, Dec. 9, 2002, at A03.
10 Id
11Id.
12Experts to Re-examine Autism,
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claim as being about the link between the vaccine preservative
thimerosal and autism, and not about the link between the vaccine itself
and autism. Meanwhile, the federal Vaccine Court placed the parents of
autistic children on a holding pattern because the Court issued a twoyear stay so that scientific evidence concerning the possible link
between vaccines and autism can be compiled.1 9
Another interesting wrinkle to this legal battle is that the United
States executive and legislative branches seem to have taken sides. In
the legal fight between parents of autistic children and vaccine makers,
members of the federal government clearly support the vaccine makers.
Two things solidify this advocacy for the vaccine makers: (1) the Bush
administration asked the Vaccine Court to seal all documents from
cases concerning whether childhood vaccines caused autism, and (2)
Congress added a last-minute rider onto the Homeland Security Act
that protected the vaccine maker, Eli Lilly, from vaccine-injury related
lawsuits. 20
Therefore, the stage is set for a high-stakes showdown in the
United States courts between parents of autistic children and vaccine
makers. This article, in Part II, will examine the current scientific
literature that is at the heart of each and every lawsuit. This article, in
Part III, will examine the legal issues in the current vaccine/autism
litigation, and also compare and contrast the different lawsuits seen in
the federal court system versus those seen in the, state court systems.
Finally, this article, in Part IV, will discuss the current lawsuits in
context of the United States executive and legislative branches actions
that tend to favor the vaccine makers.
H. SCIENTIFIC STUDIES ON THE POSSIBLE CONNECTION
BETWEEN CHILDHOOD VACCINES AND AUTISM
Autism is a debilitating disorder that is characterized by repetitive
behavior, abnormal movement, and social stigma." Physicians first
described autism as strictly a behavioral problem in children, and
therefore, it was initially studied primarily by the psychiatric
community. However, while a biological cause for autism has not been
'9 In re Claims for Vaccine Injuries Resulting in Autism Spectrum Disorder or a
Similar Neurodevelopmental Disorder v. Sec'y of Health and Human Services, 2002
U.S. Claims LEXIS 365, at *4 (Fed. Cl. Jul. 3, 2002).
20
Fredrick Sweet, Bush Blindsides ParentsofAutistic Children,INTERVENTION
MAG., Dec. 1, 2002 at
http://www.interventionmag.com/cms/modules.php?op=modload&name=News&file
=article&sid=254
2 Bernard, supra note 2, at 462.
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found, scientists in the medical community have been able to diagnosis
a biological picture in the bodies of children stricken with autism. The
medical consensus is that certain children have a genetic predisposition
to getting autism, but that autism will only manifest if it is first
triggered by an environmental factor.22 For example, it is hypothesized
that autism might be triggered by toxic levels of mercury in the body.
Certain scientists in the medical community hypothesize that
the source of toxic levels of mercury comes from childhood vaccines
that contain the preservative thimerosal, which is a mercury-based
compound. 23 The scientific evidence that childhood vaccines (through
the preservative, thimerosal) cause autism is inconclusive. Several
studies point to a link between childhood vaccines and autism, while an
equal amount of studies point to no possible link between childhood
vaccines and autism. The following gives a snapshot of the latest
scientific evidence on whether thimerosal-containing childhood
vaccines cause autism.
A. The Case FOR a Causal Relationship Between
Childhood Vaccines and Autism
A study published in 2003 by the Genetic Centers of America noted
that the prevalence of autism in United States children rose
exponentially between the mid-1980s and the mid- 1990s. 2 4 This study
used mathematical models to calculate odds of getting a
neurodevelopmental disorder (like autism) versus the dosage of
mercury children typically received from a vaccine regiment that had
thimerosal-containing vaccines." Based on the mathematical statistics,
the study concluded that the occurrence of neurodevelopmental
disorders following a vaccine regiment that included thimerosalcontaining vaccines was not coincidental.
Another study published in 2003 by SafeMinds examined levels
of mercury in the first haircuts taken from children. Hair samples were
obtained from 94 children with autism and compared to 45 age- and
gender-matched controls. 27 Mercury levels in the hair were
significantly different when autistic children were compared to the
22 Bernard

Rimland, Vaccines and Autism, 33
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"3Id. at 711.
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control children.28 The excretion pattern (or the ability of the body to
rid itself of mercury) was significantly reduced in the autistic children.2 9
In addition, mercury levels varied significantly between autistic
children that were diagnosed as having either mild, moderate, or severe
cases of autism.3 °
A review study by ARC Research was published in 2001, which
stated that exposure to mercury can cause immune, sensory,
neurological, motor, and behavioral dysfunctions that were similar to
the same dysfunctions seen in autistic children. This study also stated
that the medical literature and United States government data suggested
that many cases of autism are induced by early mercury exposure from
thimerosal and that the genetic and environmental factors established
that some children have a predisposition whereby thimerosal exposure
leads to the adverse effects of autism.3 '
The Autism Research Institute published a review study in
2002. This study noted that autistic children had a particular immune
profile, characterized by decreased immune indices, activation of the
inflammatory immune system, and increased biological markers for
autoimmunity.3 This review study noted that the immune profile for
autistic children may be considered related to the similar immune
profile a person has after prolonged mercury exposure.
Finally, research from Northeastern University has established
an apparent link between exposure of certain neurodevelopment toxins
(like the mercury-based thimerosal) and the possibility of developing
neurodevelopment disorders (like autism).33 This study is unique in that
it looks at the precise molecular mechanism that leads the
neurodevelopment toxin to cause the neurodevelopment disorder. In
this study, scientists found that certain molecules stimulate the neuronal
cells and that compounds like thimerosal effectively shut down the
pathway that leads to this neuronal stimulation.3"

"8Id.at 280.
29
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B. The Case AGAINST a Causal Relationship Between
1; Childhood Vaccines and Autism
A 2003 study of data from the Danish Psychiatric Central Research
Register examined the prevalence of autism is the Danish population
between 1971 and 2000.36 While the United States began to phase out
thimerosal from childhood vaccines in 1999, Denmark had already
done the same thing in 1992. This study examined if there was any
difference in the rate of autism in Danish children before 1992 when
thimerosal was in childhood vaccines and after 1992 when thimerosal
was removed from childhood vaccines.37 A total of 956 children in
Denmark were diagnosed with autism between 1971 and 2000, and the
researchers noted that the trend of a higher incidence of autism
continued to occur after 1992, even though thimerosal had been
removed from childhood vaccines. In other words, the discontinuation
of thimerosal had no effect on autism rates continuing to rise, thus
suggesting that there is no link between childhood vaccines containing
thimerosal and autism.39
The Statens Serum Institute in Copenhagen administered a
similar study in Denmark.4 ° This study looked at 467,000 children born
between 1990 and 1996. 4' Similar to the previous study, it was able to
compare children that received thimerosal-containing vaccines prior to
1992 against children that received non-thimerosal containing vaccines
after 1992.42 This study again found that in the Danish population there
was no difference in autism rates between those children who took
thimerosal and those children who did not take thimerosal. 3
The Epidemic Intelligence Service Program (a division of the
Centers for Disease Control) published a study in 2003 that showed no
link between thimerosal-containing vaccines and autism." In this study,
36 Richard

Reading. Thimerosal and the Occurrence of Autism: Negative
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researchers used computerized databases from two health maintenance
organizations (HMOs) to search for a link between neurodevelopment
disorders (like autism) and thimerosal exposure. 5 In all, the study
examined records for 124,170 infants born between 1992 and 1999, and
dosages of calculated mercury exposure from thimerosal-containing
childhood vaccines did not correlate with relative risk factors of
autism.46
The same review study by the Autism Research Institute
(discussed earlier) also noted that while immune profiles are similar in
autistic children and those suffering from toxic mercury exposure,
thimerosal by itself might not be the only source of mercury. This
review stated that nutritional status, food intolerances, concomitant
infections, and other toxic influences also might play a role in the
development of autism.48 In addition, the study on mercury levels in
hair (also discussed earlier) also stated that mercury levels in infants
had a correlation to the fish consumption of their mothers.49
The National Institute of Allergy and Infectious Disease stated
that in a review of the scientific literature, it was shown that babies
eliminate the mercury found in thimerosal within days. This data
suggests that any mercury exposure for thimerosal is quickly excreted
out of the body such that it is unlikely that the mercury is around long
enough to cause any neurological damage.' °
C. Summary of the Scientific Literature
In summation, all the scientific studies concerning thimersoalcontaining childhood vaccines and its possible causal relation to autism
paint an inconclusive picture. The Institute of Medicine hoped to close
the door on the issue back in 2001 when it issued a report that stated
emphatically that there was no evidence that thimerosal-containing
vaccines caused any harm.5 This report was based on the opinions of
experts from the Centers for Disease Control, from Food and Drug
Administration reports, and from numerous epidemiological studies.
While the attempt might have been to give a conclusive statement that
there was no link between thimerosal-containing vaccines and autism,
Id.at 1044.
4"Id.at 1042.
Rimland, supranote 22, at 714

41
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NIAID Research
on Thimerosal (May 2004),
available
http://www.niaid.nih.gov/factsheets/thimerosal.htm (last visited Nov. 29, 2004).
I'
Immune
to Reason, WALL ST. J., Oct. 23, 2001, at A26.
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the report, in fact, did just the opposite when it also added that it was
still "biologically plausible" that mercury exposure could have an
effect on autism and therefore thimerosal should be removed from
childhood vaccines. 3 In fact, the Institute of Medicine's report simply
fueled the flames of the debate, so much so, that it is now re-examining
the issue less than three years after the publication of the original
report.
III. LEGAL ISSUES AND CURRENT
VACCINE/AUTISM LITIGATION
Congress created the NVICA to expedite lawsuits and to protect
vaccine makers form excessive and costly litigation. 4 The purpose of
this Act is to be beneficial to both the person suffering from a vaccinerelated injury and to the manufacturer of the vaccine. It is beneficial to
the person suffering a vaccine-related injury because the person needs
only show causation between the vaccine and the injury and not
negligence on the part of the vaccine maker.5 It is also beneficial to the
vaccine maker because damages are not awarded from the
manufacturer's pocket, but rather out of a federal fund that was
generated by adding a cost of 75 cents to every vaccine shot issued 6
However, many people who suffer vaccine-related injury (and
especially the parents of children with autism), see the NVICA as a
hindrance rather than being helpful. They find it a hindrance because
the NVICA places a cap on damages for pain and suffering or
emotional distress at $250,000.17 In addition to this cap on punitive
damages, a person may also recover actual nonreimbursable medical
and rehabilitation expenses, reduced earning capacity or lost wages,
and reasonable attorneys'

fees and costs. 5 8 The NVICA is also

considered a hindrance by parents of autistic children because it
prohibits them from filing a lawsuit in a civil court where there are no
caps on damages until after a petition has been filed first with the
federal Vaccine Court.59 Currently, all pending petitions regarding
vaccine injury from thimerosal-containing vaccines have been issued a
53Id.

" See Shadie, 254 F. Supp. 2d, at 513.
55Id.

Wagner, supra note 9, at A03 (As of the date of this reference, the NVICA had
paid out $1.4 billion dollars on 1,775 claims).
56
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58See
59 Id
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stay while the court allows for scientific discovery (which as shown
earlier the data are still inconclusive). 6°
Therefore, the current legislation has set the stage where parents
of autistic children prefer to have lawsuits decided in state civil courts
and vaccine manufacturers prefer to have lawsuits decided in the
federal claims court." What follows is a look at some of the current
cases and current issues in the United States court system, and how the
battle lines are being drawn on what jurisdiction the legal battle should
take place.
A. The Need and Benefit of Putting a Stay on
All Cases Pending Scientific Discovery
In July 2002, the Vaccine Court issued a general order that put all
autism cases seeking damages from -vaccine makers on hold.62 The
Court noted that the hold was unusual because of the large number of
cases being filed in a short period of time.63 In July 2002, the Vaccine
Court had more than 400 cases claiming a link between thimerosalcontaining vaccines and the onset of autism. 64 Of these 400 cases, more
than 300 of them were filed in the six months prior to the Court ordered
stay.65 In addition, the Court stated that even more civil suits were being
filed around the country and that most of those courts were dismissing
the claims with the instructions that all claims must be first filed with
the Vaccine Court. 66 Hence, the Court recognized that the number of
cases filed in the Vaccine Court was only going to grow exponentially.
Therefore, the Court opinion stated that the large number of
vaccine/autism cases
would "stretch thinly the resources of both the
67
court and the bar.",
In the name of efficiency, the Court held that there would be a
stay on all vaccine/autism cases for two years, in which time there
would be scientific discovery on the possible causation between
thimerosal-containing childhood vaccines and the development of
autism. 8 The Court opinion stated that "a uniform evidentiary record
would assist in fairly and expeditiously resolving such claims. ' , 69 In
See In re Claims for Vaccine Injuries, 2002 U.S. Claims LEXIS 365, at * 16.
Warner, supra note 9, at A03.
62See In re Claims for Vaccine Injuries, 2002 U.S. Claims LEXIS 365, at * 16.
63 Id. at *2.
6

61

64id.
65

id.

67 In

re Claims for Vaccine Injuries, 2002 U.S. Claims LEXIS 365, at *4.

Id. at *11.
69Id. at *1.
6
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other words, having a uniform evidentiary record would allow the
Vaccine Court to make a ruling concerning causation between
thimerosal-containing childhood vaccines and the development of
autism in one broad stroke that would cover all pending and future
cases before the Court.
At first glance, this ruling by the Vaccine Court seems
detrimental to the parents of autistic children. For example, for the
parents of autistic children, two years is a relatively long time for a case
to sit in discovery. In fact, the purpose of the NVICA, which set up the
Vaccine Court, was to give petitioners a relatively expedient route of
obtaining relief.7 ° However, the Court opinion issuing the two-year stay
noted that it was often the attorneys of the parents of autistic children
who were requesting the additional discovery time such that scientific
proof could establish causation.'
The Office of Special Masters (OSM) oversees the collection of
scientific discovery for the Vaccine Court.72 An Autism Master File
will be compiled and put on record with the Court at the end of the
two-year period.73 The OSM has a two-step procedure, including
conducting an inquiry into the general causation issue and applying the
conclusions reached in the causation inquiry to all the individual cases
before the Vaccine Court. 4
All attorneys of the parents of autistic children were not given a
voice in the evidentiary proceedings; rather, a representative team of
the petitioner's lawyers was selected to represent the interest of all the
petitioners. 7 The Court proposed the bulk of the two years be used in
the discovery portion (i.e., the first part of the two-step procedure) that
would examine general causation. 6 The discovery process includes
scientific experts from both sides.77 In other words, the discovery
includes scientists stating that there is causation between thimerosalcontaining vaccines and autism, and scientists stating that there is no
causation between these vaccines and autism. Finally, the Court
appointed Special Master George Hastings to preside over the
proceedings and to make any and all necessary rulings on whether there

7

0 Id. at *13.
Id.at *12.
I,
72See In re Claims for Vaccine Injuries, 2002 U.S. Claims LEXIS 365, at *7.
IId. at *13.
*7.

7, Id.at
75Id.
76Id.at

*8.

"7See In re Claims for Vaccine Injuries, 2002 U.S. Claims LEXIS 365, at *6.
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is causation between thimerosal-containing childhood vaccines and the
development of autism.78
In January 2003, the United States District Court for the Eastern
District of Louisiana in Case v. Merck also issued a stay on an
individual case citing essentially the same reasons given by the Vaccine
Court. The Court noted that the Vaccine Court, which handled
hundreds of claims similar to the one particular claim in its court also
issued a stay so that the issue of causation could be resolved; however,
unlike the Vaccine Court, the District Court did not set a time-table as
to how long the stay would be.7 9
The Court held that a stay was justified because it "would
economize the time of the Court, the counsel, and the litigants." 80 The
Court further reasoned that causation was an essential element in order
to recover damages, and therefore, it was in the best interest of the
plaintiffs to have the issue of causation settled in discovery.8 ' Because
this fact of causation was both necessary and unresolved, the Court
held that the plaintiffs (the parents of the autistic child) would not be
prejudiced by a stay.82
Case also had two additional rulings. First, the Court held that
the petitioner can obtain a loss of consortium 'award' from a state court
and also obtain compensation from a vaccine injury through the
Vaccine Court (discussed more in detail below), and second, Eli Lilly
was considered separate from the other defendant vaccine makers
because of the special protection it received from the Homeland
Security Act of 2002 (also discussed more in detail below).83
B. An Examination of Vaccine/Autism Cases
Actually Decided by the Vaccine Court
As mentioned, hundreds of cases sit before the Vaccine Court on
whether a causal link between thimerosal and autism exists. Below is a
snapshot of some of the decisions reached by the Vaccine Court
concerning both legal issues and legal procedures.
Wood v. Secretary of The Department of Health and Human
Services demonstrated that statute of limitation remains an important
issue in vaccine/autism cases. The petitioners (parents of an autistic
child) filed a claim in September 2002 relating to vaccines the child
" Id. at *8.

79 Case

and Redding v. Merck, 2003 U.S. Dist. LEXIS 770; CCH Prod. Liab.
Rep, P16,589, at *9.
'0Id. at *8.
81Id.
12Id.
83Id.

at *9.
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received in 1996 and 1997. 84 The respondents (vaccine makers) asked
for a dismissal contending that the petition was untimely filed.85
Therefore, the statute of limitation had run, thus meaning that the case
should be dismissed.16 The Vaccine Court noted that petitioners actually
filed two separate claims: (1) that vaccines received in 1996 and 1997
caused the autism, and (2) that vaccines received in April 2000
"significantly aggravated" the autism." The Court held that the
NVICA allows for a petition to be filed within "36 months after the
date of the occurrence of the first symptom or manifestation of onset or
of the significant aggravation of such injury." 8 Therefore, the Vaccine
Court held that the petition concerning vaccines in 1996 and 1997 was
not timely filed, but the petition concerning the aggravation of vaccinerelated injury in 2000 was timely filed. 9
In Kuehn v. Secretary of the Department of Health and Human
Services, petitioners (parents of an autistic child) did not receive the
same result as petitioners in Wood when challenging dismissal of a
petition based on the statute of limitation. Petitioners asked for a
reversal of a dismissal order claiming that a strict application of the
NVICA violated their constitutionally protected right of due process
and right to have a jury resolve their state common law claim as
protected by the Seventh Amendment. 9° The Vaccine Court denied the
petitioners' request, holding that the Court did not have the authority to
resolve constitutional questions.9" In addition, the Vaccine Court cited
that the Federal Circuit refused to apply equitable tolling to NVICA
cases.9 2 This strict ruling on not allowing tolling of the statute of
limitations can be a serious roadblock to parents of autistic children
because often times the autism is not diagnosed until well beyond the
time of vaccinations. It is important to note that a child might have
autism develop over a slower period of time; therefore, just because
clinical symptoms are not diagnosed does not mean that a child is not
suffering from the autistic disorder.

84

Wood v. Secretary of Health and Human Serv., 2003 WL 23218062 (Fed. Cl.),

at *1.
85
Id.
86

id.

87

88

1d.

Id.

'9See Wood, 2003 WL 23218062 (Fed. Cl.), at * 1.
90Kuehn v. Sec'y of the Dep't of Health and Human Serv., 2003 WL 22416683
(Fed. Cl.), at * 1.
9'Id at *3.
92Id.at *2.
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Tebecherani v. Secretary of the Department of Health and
Human Services determined that when considering if a vaccine injury
occurred, judgment should be akin to deciding a motion for summary
judgment in that all the evidence should be viewed in the light that is
most favorable to the petitioner. This case was remanded because the
Special Master compiling the evidence failed to consider school records
which were relevant to the issue of whether the child in question
exhibited an onset of injuries within a 72-hour time after her
vaccination. 93 A credible demonstration of injuries in this 72-hour time
period can be considered prima facie proof of a vaccine-related injury;
however, a petitioner may still prevail by demonstrating a
preponderance of evidence that the vaccine significantly aggravated an
injury. 94 The former scenario described here is atypical of an autism
case (although the child in question here did have autism) because the
development of autism is seen often well into a child's first or second
year of life and not as an immediate reaction to a vaccine shot. 95 The
Special Master in this case placed great weight on the child being
diagnosed early with autism, and therefore, denied recovery of damages
mostly based on whether there was an acute injury following a
vaccination shot.
Finally, another atypical case of a petitioner seeking relief is a
vaccine/autism case is seen in Stewart v. Secretary of the Department
of Health and Human Services. In this case, the parent of a child with
autism essentially asked the Vaccine Court to allow a short-form
petition that would result in a Court ruling despite a stay being ordered
for scientific evidence to be gathered. The parent of the autistic child
bases this claim on the literal wording of the NVICA that says a
decision on a petition must be made within 240 days of the petition
being filed (with an allowance for a 180-day extension).96 This wording
is within the scope of what Congress intended when it passed the
NVICA because Congress was mindful it did not want petitioners to be
locked indefinitely in the Vaccine Court.97 In fact, Congress conceived
the NVICA on the principle that petitioners should have access to
expedient relief for vaccine-related injuries. 9 Naturally, the vaccine
makers asked the Vaccine Court to deny this short-form petition
93Tebcherani

v. Sec'y of the Dep't of Health and Humans Serv., 55 Fed. Cl. 460,

463 (2003).
94M. at 472.
9'Id. at 473.

96 Stewart v. Sec'y of Health and Human Serv., 2003 WL 22300298 (Fed. Cl.), at
*5.
97

Id.

98

Id.
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because the Court should not be making any definitive ruling while the
issue of general causation was still being considered under the Vaccine
Court's order. The Vaccine Court agreed with the vaccine makers
holding that the stay issued by the Court essentially trumps the 240-day
provision written into the NVICA. 99
Even though the Vaccine Court had a two-year timetable to
gather scientific evidence concerning causation for vaccine/autism
cases, it is unknown whether any kind of consensus regarding causation
will be reached at the conclusion of those two years. In fact, the
Institute of Medicine which supposedly gave a definitive report in 2001
stating there was no link between thimerosal-containing vaccines and
autism decided to reexamine the issue less than three years later.' °
Therefore, any consensus that the Vaccine Court may make at the end
of the two-year period might not be considered credible in light of the
Institute of Medicine decision to re-examine the issue once again.''
The danger for parents of autistic children is that the Vaccine Court
might extend this two-year stay, in which case the potential of parents
getting locked into the Vaccine Court indefinitely (as discussed in
Stewart) might become a reality.
C. Comparing and Contrasting Federal and State Jurisdiction for
Vaccine/Autism Lawsuits
In Shadie v. A ventis Pasteur,the parents of an autistic child brought
action in a state court against numerous vaccine manufacturers
claiming the injury their child suffered as a result of taking vaccines
was covered by state laws for strict product liability, negligence, and
fraud.102 The vaccine manufacturers removed the case to a federal court
and moved for dismissal.' 3 Parents moved to remand case back to the
state court.' 4 The United States District Court for the Middle District of
Pennsylvania held in favor of the parents stating that (1) the NVICA
did not completely preempt state law, (2) interpretation of what made
up "vaccine-related injury within the meaning of the NVICA was
insufficient to confer federal question jurisdiction, and (3) there was not
complete diversity between the defendants and the plaintiffs. 5
The important element to this case is whether a federal act
equates to a federal question thus necessitating the case be removed to
9 Id. at *7.

'0See Experts to Re-examine Autism, Vaccine Debate, supra note 4.
101Id.

'02
See Shadie, 254 F. Supp. 2d 509, at 511.
103id.
104Id.

1o5Id.
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a federal jurisdiction.' °6 The "well pleaded complaint rule" is the
standard the court uses to determine if there is a presence or absence of
a federal question." 7 This rule provides that federal jurisdiction exists
only when a federal question is presented on the face of the plaintiffs
well pleaded complaint. 0 8 However, mere presence of a federal issue
does not automatically confer jurisdiction to the federal level.' °9 The
vaccine makers argued that the NVICA created an exclusive remedy in
the Vaccine Court and any claims brought under state laws must only
be brought after remedies were exhausted through the Vaccine Court.
The United States District Court rejected both these arguments by
holding that the NVICA did not completely preempt state law because
it only made it a prerequisite to file first with the Vaccine Court prior to
filing any state law claims (such as product liability, negligence, and
fraud)." In other words, the wording of the NVICA does not shut the
door to those wishing to file a complaint in state court; rather it just
states that a claim must first be filed with the Vaccine Court prior to
any fillings under state law."'
Additionally, a state case may be removed to a federal court if
there is complete diversity."' Complete diversity exists when the
plaintiffs and all the defendants are from different states."3 In this case,
the plaintiffs lived in Pennsylvania and two defendants (Aventis and4
as well."
GlaxoSmithKline) were considered citizens of Pennsylvania
Defendants argued that these two companies were fraudulently added
to defeat diversity."' The Court, however, stated that this theory was
suspect because it asked the Court to extend the fraudulent joinder too
all doubts regarding
far in light of the Supreme Court's opinion that
6
removal are to be resolved in favor of remand."1
Likewise, the vaccine manufacturers in Case sought a dismissal
because they claimed all vaccine injury cases must first be filed in the
Vaccine Court. In fact, in this particular case, the defendant vaccine
makers were mistaken in that the plaintiffs had previously filed a claim
in the Vaccine Court. The Court in Case was similar to the holding in
'06M.d at 515.
'07See Shadie, 254 F. Supp. 2d 509, at 516.
108 Id.
10

'

Id.

10Id.
111
Id.
112

See Shadie, 254 F. Supp. 2d 509, at 518.

113 id.

114Id.
115 Id.
116 id.

DEPAUL JOURNAL OF HEALTH CARE LAW

[Vol.8.1:305

Shadie in that it recognized that the NVICA did not prohibit parents of
autistic children from bringing civil suits in state courts. The only
prerequisite to filing a claim in a state civil court is that a claim be filed
first with the Vaccine Court, which was consistent with the facts in
Case. Specifically, the Court held that a parent of an autistic child could
recover a loss of consortium award from a state court and also receive
compensation from the Vaccine Court for a vaccine-related injury
(emphasis added).' 7
The Case and Shadie cases represent wins for the parents of
autistic children who wish to have their lawsuits tried in a state court;
however, it has yet to be decided if a state court will in fact find proof
of product liability, negligence, or fraud on the part of the vaccine
manufacturers." 8 However, these cases do demonstrate that parents of
autistic children tend to feel that their best chance of winning damages
are in state courts, and the vaccine makers in turn are equally vehement
in their desire to have cases in the federal courts where their likelihood
of success is greater.
IV. THE EXECUTIVE AND LEGISLATIVE BRANCHES TAKE
SIDES IN THE VACCINE/AUTISM DEBATE
While the courts have issued stays to allow for scientific discovery into
whether thimerosal-containing vaccines cause autism, the executive
and legislative branches of the federal government have taken
affirmative actions that have the intent to limit these kinds of lawsuits.
The executive branch in November 2002 asked the Vaccine Court to
seal from the public all of it documents concerning whether thimerosalcontaining vaccines cause autism.' Meanwhile, the legislative branch
in the same month attached a last-minute rider to the Homeland
Security Act that essentially gave immunity to Eli Lilly (the company
that invented thimerosal) from being sued for any vaccine-related
injury. 20 The following discussion will examine both of these actions
by the govenment and their intended effect on vaccine/autism lawsuits.
A. Sealing the Vaccine Court Documents
Department of Justice attorneys in the George W. Bush Administration
requested that the Vaccine Court seal all documents on autism cases

..
7See Case, U.S. Dist. LEXIS 770, at *8.
118

See Shadie, 254 F. Supp. 2d at 509.

"9
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that are part of the NVICA proceedings.12' A Justice Department
spokesman stated that the goal of sealing the documents was to protect
the Department of Health and Human Services, which is the opposing
party to the parents of autistic children in all vaccine/autism suits filed
under the NVICA. 122 The reasoning is that the Department of Health
and Human Services has the authority to decide when to release23
evidence on whether thimerosal-containing vaccines cause autism.'
Therefore, the Justice Department argued that the autonomy of the
Department of Health and Human Services to release this information
would be compromised if the public already had access to the discovery
documents from the Vaccine Court. 24 However, opponents of this
argument suggest that if the Department of Health and Human Services
goal is to issue a statement on whether thimerosal-containing vaccines
action infringes on this goal
cause autism then the Justice Department's
25
by restricting the fact-finding process.1
Attorneys for parents of autistic children retort that the real
reason behind the Justice Department's request is a clever attempt to
keep the information out of state civil courts, where jury awards might
be extremely large against the vaccine makers. 26 These attorneys argue
that the request to seal documents is, in effect, a way to punish the
parents of autistic children who file suit because it would require them
to incur the extra time and expense of having to regenerate the evidence
that was sealed in the Vaccine Court.'27 To make this point, an attorney
that represents hundreds of families with autistic children stated that
this policy really favors a lawyer like himself because it allows him to
bill more for unnecessary research because the government blocked
access to information.' 28 Hence, the increased legal costs that a parent
of an autistic child may incur from the records being sealed would act
on with a civil lawsuit after a decision from
as a deterrent from pressing
29
the Vaccine Court.
The Justice Department answered this argument by saying that
parents with autistic children that choose to forgo federal compensation
from the NVICA and take their cases to civil court should not have the
121Sarah
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ST. J., Nov. 27, 2002, at D3.
122 Id.
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advantage of having the entire discovery from hundreds of cases at
their disposal. Federal law seals most documents generated in
individual cases; however, the sealing of documents has never been
applied to a procedural order by the court (in this case, the procedural
order to generate one
discovery process to be applied to all
3

vaccine/autism cases).1 0

Finally, it is argued by scientists that the sealing of these
documents may have an effect on the scientific community as well as
the legal community.' This argument goes that if the court documents
show the link between thimerosal-containing vaccines and autism is not
strong then scientists would be more inclined to devote their resources
to other needed areas of research.'3 2 In contrast, if, in fact, the court
documents showed a strong link between thimerosal-containing
vaccines and autism, then scientists may benefit from the release of
evidence because it would help focus their resources on the
mechanisms involved, which might lead to a possible cure.'33
Therefore, the argument goes that the sealing of evidence hurts the
scientific process no matter what. In fact, keeping information secret is
antithetical to the basic philosophy of science where all the data of the
past is used as a foundation for future hypotheses and research.
Whether the intent to seal the vaccine/autism documents before
the Vaccine Court is intended to protect the Department of Health and
Human Services autonomy or to punish parents of autistic children who
bring lawsuits, there is no question that the request drapes the
vaccine/autism debate into a shroud of secrecy.' 34 This shroud of
secrecy is even more evident considering the request came the same
week35 that the last-minute rider was added to the Homeland Security
1
Act.
B. Protecting a Vaccine Maker through
the Homeland Security Act
The Homeland Security Act of 2002 was a massive 500-page document
that Congress passed in response to protecting the United States from
Todd Zwillich, US GovernmentAsks Court to Seal Vaccine Records (Nov. 26,

130
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terrorist acts.'36 Language that acted as a shield for vaccine makers
mysteriously appeared as a last minute rider.'37 The rider did not have
an author so it is not known if it originated with the President or with a
particular member of Congress. ' This last minute provision
specifically protected the pharmaceutical company Eli Lilly, who
invented thimerosal and who used this preservative in their vaccines all
the way through the 1980s.' 39 President George W. Bush appointed
Chairman and CEO of Eli Lilly, Sidney Taurel, to the Homeland
Security Advisory Board; however, a spokesman for Eli Lilly expressly
denied that the company had any role in pushing the last-minute
change.'4°
A group of moderate Republican Senators (Olympia Snowe (RME), Susan Collins (R-ME), and Lincoln Chafee (R-RI)) were able to
get the Eli Lilly provision removed from the Act in January 2003,
approximately two months after the Act had passed. 4' As seen in the
Case lawsuit mentioned above, this relatively short period of time was
sufficient for Eli Lilly to make a motion for the court to use this Act as
a way to protect it from product liability in a state civil court. Eli Lilly
was one of five vaccine makers that were named as defendants in Case,
and it was the only one of these defendants that was able to seek
dismissal of the lawsuit by citing the Homeland Security Act.
The moderate Republican Senators who were responsible for
the last-minute Eli Lilly provision being reversed did not state that they
objected to Eli Lilly and other vaccine makers receiving protection,
rather their objection was the "cloak of night" addition of the provision
42
into the Homeland Security Act with no debate or discussion.
Furthermore, the addition of this provision clearly questions the
connection between thimerosal-containing childhood vaccines and
homeland security?' Also, in line with the moderate Republican
Senators objections, if the provision was to be added to the bill why
should there not be any congressional hearings before denying parents
of autistic children the opportunity to file a lawsuit?'"
,36
Thimerosal Immunity to Pork, Scientific America (Feb. 2003), available at
http:www.mindfully.org/Health/2003/Thimerosal-Homeland-SecurityFebO3.htm (last
visited Nov. 30, 2004).
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Defenders of the provision protecting Eli Lilly (as seen in
newspaper editorials and not by any actual member of Congress) state
it was good law because tort lawsuits have the potential to bankrupt
vaccine makers.' 45 As an example, one particular lawsuit is seeking $30
billion in damages alone.146 These editorials in favor of the provision
continue their argument by stating that now only four companies
devote funds to researching new vaccines and that a large portion
of the
147
money dedicated to vaccines are entangled in fighting lawsuits.
Additionally, supporters of this Eli Lilly provision argued that
the fear of thimerosal injuries is greatly exaggerated.1 4 This argument
stated that the combined levels of thimerosal from a full vaccination
schedule would only theoretically put mercury levels at the EPA
mercury guideline for safety and does not address the fact that mercury
can be excreted from the body over the course of the two years that
children receive their initial vaccines. 149 The argument also noted that
scientists for the EPA stated that the cutoff level as to what is safe and
what is unsafe is unusually low, and therefore, thimerosal being taken
out of vaccines was done more 50to quell parents fears rather than
because of any actual safety issue.
However, what is not argued in these editorials is that much of
the research to develop vaccines are funded by the United States
government and not by individual pharmaceutical companies who shy
away from this research because it has low profit margins. In addition,
none of these editorials ever answer the question of why it was
necessary to have this specific provision be attached to a bill

concerning homeland security?
Also quiet on the issue of how thimerosal-containing vaccines
are connected to homeland security are all elected members of
Congress.'' House Republican leader Dick Armey (R-TX) said the
provision "was something that the White House wanted"; however,
neither Armey nor anyone in the White House took credit for it.'52
Although the author of the provision is not known, Eli Lilly is a very
strong campaign contributor to both President George W. Bush and
many Republican members of Congress.'53
141
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Since no one has claimed to have authored the provision that
protected Eli Lilly from lawsuits coming from parents of autistic
children, no one is stating the only possible connection to homeland
security is that vaccines may be necessary in the event of a bioterrorism
attack. The argument is very tenuous at best because the provision
specifically singled out protection from a childhood vaccine and not
from any vaccine that may be necessary in the face of a bioterrorism
attack.
In the end, the last-minute provision was most likely business as
usual for Congress, which is known to add unrelated riders onto major
bills that are helpful to their friends (e.g., campaign contributors).'54
Thankfully for the parents of autistic children who wish to continue
their lawsuits, there was enough of a public uproar that ultimately the
provision was removed.'55 The removal of this provision was another
small "win" for the parents of autistic children, but it may be a win
that foreshadows an ominous picture."' The vaccine makers, like Eli
Lilly, have friends in high places, and the executive and legislative
branches of the federal government have appeared to taken the side of
the vaccine maker and against the parents of autistic children in the
vaccine/autism debate.'
V. DISCUSSION
The scientific process is a slow process as exemplified by the amount
of autism research over the last 40 years that has yet to discover what
causes the disorder. In contrast, the NVICA was designed by Congress
to be a fast process to provide relief to those that suffered from vaccine
injuries. When these two processes collided in the case of whether
thimerosal-containing vaccines caused autism, the slower scientific
process ultimately won out. Despite the NVICA being designed to give
petitioners expedient relief, the Vaccine Court decided to issue a twoyear stay on all vaccine/autism cases such that scientific discovery
could be completed. However, two years does not appear to be enough
time to clarify all the scientific questions on whether thimerosalcontaining vaccines cause autism.' In fact, the Institute of Medicine,
which in 2001 declared that there was no link between thimerosalcontaining childhood vaccines, decided in 2004 to reexamine this issue
14 Id.
155 Id.
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in light of new scientific evidence that pointed to the possibility there
was a link between childhood vaccines and autism.'59
While there are several new studies that indicate that there may
be a link between thimerosal-containing childhood vaccines and
autism, there are equally as many new studies which reiterate that there
is no link between the vaccines and autism.16 All of which means that
parents of autistic children are on a holding pattern while the Vaccine
Court weighs the merit of these new and increasing inconclusive
scientific studies.
The "hurry up and wait" nature of these vaccine/autism cases
leaves parents in an uncomfortable dilemma because on one hand, their
own attorneys are asking for time to compile scientific evidence that
should be favorable to their clients; and on the other hand, these parents
often need immediate relief to help pay for the medical costs of caring
for their autistic children. In addition, the Vaccine Court is only the
first step for parents of autistic children if they wish to try and go after
the "big bucks" which may be found in the state civil courts.
Finally, for parents of autistic children it seems as if not only
are the super-wealthy pharmaceutical companies against them but so
are the executive and legislative branches of the federal government.
The Bush administration and the Republican-led Congress have taken
affirmative steps that would cut off vaccine/autism petitioners at the
knees. 6' In effect, the White House and Congress, by requesting that

documents be sealed and by successfully adding a rider (since
removed) to the Homeland Security Act that shields Eli Lilly from
vaccine-injury lawsuits, are essentially saying to the parents of autistic
children that they should not even have their day in court. 62' The ultrapowerful trinity of the White House, Congress, and pharmaceutical
companies (as big campaign contributors) provides what would seem to
be an insurmountable force in the face of63parents with autistic children
who seek relief through the court system.'
As silly as it may initially seem, on the other side of the debate
is the opinion that pharmaceutical companies actually need protection
from the federal government. Vaccines have served the public well, yet
partially because of the expense of litigation, many pharmaceutical
companies have stopped making vaccines. In fact, the number of
vaccine makers in the United States has shrunk to only four.
159Id.
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In the particular case of thimerosal and whether it leads to
autism, vaccine makers correctly note that the reason that thimerosal
was removed from childhood vaccines had more to do with appeasing
parents who might have unnecessary fears of the reports of a possible
link to autism. The American Academy of Pediatrics and the United
States Public Health Service recommended the removal of thimerosal
from childhood vaccines because they feared that if it remained
in
6
vaccines, parents would opt to not vaccinate their children at all.' 4
Protecting vaccine makers from frivolous lawsuits would then
also serve the public because it would encourage more companies to
research and produce better vaccines.6 This idea was the genus behind
the NVICA. Vaccine makers could be free of litigation because any
non-frivolous lawsuit would be settled in the Vaccine Court with
damages being provided from a federal fund and not from the vaccine
makers.
Of course, the NVICA did not let vaccine makers off the hook
completely because the Vaccine Court was only a required first step for
petitioners seeking relief from vaccine-related injuries. The NVICA
provided that petitioners could forgo their federally funded relief and
then take their cases to the state civil courts where the pharmaceutical
companies would be on the hook if a jury awarded damages for product
liability and/or negligence. Because medical costs continue to increase
and because the Vaccine Court has a cap on damages, parents of
autistic children almost always seek to forgo the federal court in favor
of the state courts where the rewards would be richer.' 66
VI. CONCLUSION
The only conclusive thing about the scientific evidence concerning
thimerosal-containing vaccines and its link to autism is that it will be
studied for a long time to come. Likewise, the lawsuits will continue as
long as some evidence points to a possible link between these
childhood vaccines and autism. It is unknown whether an evidentiary
ruling by the Vaccine Court will provide an end-game for either the
vaccine makers or provide the will to fight on in a state civil court for
parents of autistic children.
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